Company / Total Assets
Collegium Pharmaceutical, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.7B
FY2025
5-year range
$692.1M / $1.7B
FY2021-FY2025
Trend
-0.4%
vs FY2024
Sector context
#46 of 214
Health Care
What the data says
Collegium Pharmaceutical, Inc.'s total assets of $1.7B is higher than 79% of companies in the Health Care sector (FY2025). Total Assets has fluctuated over the past 10 years, ranging from $136M in FY2017 to $1.7B in FY2024.
Based on SEC 10-K filings.
$1.7B in FY2025 with a 5-year CAGR of +20.8%. Top quartile in the Health Care sector.
Improved from $1.1B to $1.7B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +12.2%
- 5-Year CAGR
- +20.8%
- 10-Year CAGR
- -
Sector benchmark
-77.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +20.8%, indicating consistent growth.
- In FY2025, total assets decreased 0.4% year-over-year.
- Ranks #46 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.7B | -0.4% |
| FY2024 | $1.7B | +45.5% |
| FY2023 | $1.1B | -2.6% |
| FY2022 | $1.2B | +69.7% |
| FY2021 | $692.1M | +7.5% |
| FY2020 | $643.8M | +110.2% |
| FY2019 | $306.3M | +5.2% |
| FY2018 | $291.2M | +114.8% |
| FY2017 | $135.6M | -16.3% |
| FY2016 | $162.0M | +65.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026